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ABSTRACT
Background: Intestinal inflammation and malabsorption in environmental enteric dysfunction (EED) are associated
with early childhood growth faltering in impoverished settings worldwide.
Objectives: The goal of this study was to identify candidate biomarkers associated with inflammation, EED histology,
and as predictors of later growth outcomes by focusing on the liver-gut axis by investigating the bile acid metabolome.
Methods: Undernourished rural Pakistani infants (n = 365) with weight-for-height Z score (WHZ) < –2 were followed up
to the age of 24 mo and monitored for growth, infections, and EED. Well-nourished local children (n = 51) were controls,
based on consistent WHZ > 0 and height-for-age Z score (HAZ) > –1 on 2 consecutive visits at 3 and 6 mo. Serum bile
acid (sBA) profiles were measured by tandem MS at the ages of 3–6 and 9 mo and before nutritional intervention.
Biopsies and duodenal aspirates were obtained following upper gastrointestinal endoscopy from a subset of children
(n = 63) that responded poorly to nutritional intervention. BA composition in paired plasma and duodenal aspirates was
compared based on the severity of EED histopathological scores and correlated to clinical and growth outcomes.
Results: Remarkably, >70% of undernourished Pakistani infants displayed elevated sBA concentrations consistent with
subclinical cholestasis. Serum glycocholic acid (GCA) correlated with linear growth faltering (HAZ, r = –0.252 and –0.295
at the age of 3–6 and 9 mo, respectively, P <0.001) and biomarkers of inflammation. The proportion of GCA positively
correlated with EED severity for both plasma (rs = 0.324 P = 0.02) and duodenal aspirates (rs = 0.307 P = 0.06) in children
with refractory wasting that underwent endoscopy, and the proportion of secondary BA was low in both undernourished
and EED children.
Conclusions: Dysregulated bile acid metabolism is associated with growth faltering and EED severity in
undernourished children. Restoration of intestinal BA homeostasis may offer a novel therapeutic target for undernutrition
in children with EED. This trial was registered at clinicaltrials.gov as NCT03588013. J Nutr 2021;00:1–12.
Keywords: environmental enteric dysfunction (EED), bile acid, biomarkers, stunting, undernutrition,
UHPLC-MS/MS, endoscopy
Introduction
Environmental enteric dysfunction (EED; also known as
environmental enteropathy) is a major impediment to achieving
global targets for reducing childhood undernutrition (1).
Undernutrition impacts ∼22% of children aged <5 y globally
and underlies almost half of all deaths in this age group (2). EED
is also associated with an increased risk of morbidity, stunting,
and reduced oral vaccine immunogenicity in impoverished
settings (3), where inadequate water, hygiene, and sanitation are
considered critical EED risk factors (4, 5). Children fed marginal
diets and exposed repeatedly to enteropathogens develop a
chronic enteropathy, with altered structure and function of the
small intestine. Chronic mucosal inflammation, villus blunting,
and increased permeability, with reduced absorptive capacity of
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the small intestine, are the primary sequelae described in EED
patients (6). EED is also implicated in micronutrient deficiency
and intestinal antigen translocation (7, 8). However, the
underlying mechanisms and pathogenesis of EED remain poorly
understood. Dietary interventions and water, sanitation, and
hygiene measures, alone or in combination, are often ineffective
and fail to substantially ameliorate EED and its associated
stunting (3, 9). Furthermore, current EED biomarkers fail to
capture the full spectrum of EED and links to metabolism (10).
Emerging evidence from sub-Saharan Africa suggests bile
acid (BA) homeostasis is disrupted in children aged >1 y with
either EED and/or severe acute malnutrition (SAM) (11, 12).
BA function as detergents in the intestine to facilitate lipid
digestion and absorption. In the liver, bile acids play a critical
role in providing the driving force for stimulating bile flow
while also functioning as key signaling molecules that regulate
numerous metabolic pathways associated with childhood
growth (12, 13). Importantly, animal studies show BA regulate
intestinal inflammation by modulating gut regulatory T cell
homeostasis (14–16). Restoration of the intestinal BA pool was
shown to ameliorate host susceptibility to inflammation (14).
Furthermore, BA mediate colonization and maturation of the
newborn gut microbiota (17). Key findings of immaturity of
fecal microbiota in stunted children (18) and a causal role of
the small intestinal microbiota in EED propel current efforts to
develop microbiome-directed interventions against EED (19).
As part of the Study of Environmental Enteropathy and
Malnutrition (SEEM)-Pakistan, we measured the serum BA
metabolome in a large cohort of rural Pakistani children
followed longitudinally from the age of 3–24 mo for growth
and infection and biological samples were collected between
the age of 3–6 mo, and again at the age of 9 mo (2, 20).
A subset of this cohort, refractory to multiple nutritional
interventions, underwent esophagogastroduodenoscopy (EGD)
to evaluate enteropathies. Uniquely, paired samples of duodenal
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aspirates and plasma collected at the time of endoscopy
permitted us to determine the extent to which plasma bile acid
composition reflects intraluminal duodenal BA in EED. The key
findings of this study reveal, 1) persistent elevated plasma BA
concentrations, consistent with cholestasis are a feature in a
high proportion of children with growth failure, 2) specifically,
elevated serum glycocholic acid (GCA) concentrations correlate
with the severity of biomarkers of inflammation and can predict
linear growth faltering, and 3) a unique BA signature of
increased proportions of GCA and depleted secondary BA in
plasma and duodenal aspirates occurs in children with EED
refractory to nutritional intervention.
Methods
Study design and specimen collection
SEEM in Pakistan is a prospective study that enrolled children at birth
in Matiari, Pakistan, a region with high prevalence of undernutrition,
between 2016 and 2019 (2). This trial was registered at clinicaltrials.gov
as NCT03588013.
Study participants comprised a local healthy child control group
(n = 51) and a group of undernourished children (n = 365) that were
evaluated for symptoms of EED and followed for growth up to the age
of 24 mo. Undernourished children were defined by a weight-for-height
Z score (WHZ) < –2 at enrollment, whereas the healthy control cohort
was based on consistent WHZ >0 and a height-for-age Z score (HAZ)
> –1 on 2 consecutive visits between the ages of 3 and 6 mo prior to
nutritional intervention. Linear and ponderal growth for each child was
monitored monthly. Blood, urine, and feces were collected at the age of
3–6 mo and 9 mo, respectively. After enrollment, the parents/caregivers
of all participants underwent a series of educational programs to
improve the child’s nutritional status. Upon enrollment, participants
received a 4-wk home-delivered educational program that focused on
breastfeeding and complementary feeding. Counseling was performed
by the study staff using standardized teaching materials. If the WHZ
score remained < −2 by the age of 9 mo, despite the initial educational
counseling, families were shown a 10 min educational video fortnightly
detailing the best practices for complementary feeding and compliance
to the instructions was recorded during weekly home visits. Nutritional
intervention was given to 189 children who had a WHZ score < −2 at
the age of 9–12 mo using high calorie AchaMum supplementary food
containing protein and essential fatty acids. Among the undernourished
children who responded poorly to nutritional intervention, in total 63
were evaluated by EGD at the Aga Khan University Hospital (AKUH).
Biopsy specimens were obtained from these children for detailed
assessment of the histopathology of EED (Supplemental Table 1). Other
poorly responding children (n = 8) declined EGD. Given the ethical
limitation and lack of clinical justification for performing EGD on
adequately growing children, it was not possible to collect EGD samples
from local Matiari controls. Nevertheless, as a compromise, after eval-
uating the histology, the biopsied group was divided into those children
above the 50th percentile and those below the 50th percentile based
on the biopsy scoring system (Supplemental Table 2). Paired plasma
and duodenal aspirate samples were collected at the time of endoscopy
while these children were sedated and in a fasted state. Presaline lavage
duodenal aspirates were attempted and collected. It was not always
possible to collect samples from all the children at every time point,
however, a comprehensive sample size was obtained. The study design
and sample collection timeline are outlined in Supplemental Figure 1.
BA profiling using ultra-performance LC coupled with
tandem MS
The serum and plasma BA metabolome was determined by stable-
isotope dilution analysis using a fully validated LC-electrospray
ionization-MS (LC-ESI-MS) method (Supplemental Methods). In total,
the 15 major primary and secondary bile acids and their conjugates
were measured, which included cholic acid (CA), chenodeoxycholic acid
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(CDCA), deoxycholic acid (DCA), lithocholic acid (LCA), glycocholic
acid (GCA), glycochenodeoxycholic acid (GCDCA), glycodeoxycholic
acid (GDCA), glycolithocholic acid (GLCA), glycoursodeoxycholic
acid (GUDCA), taurocholic acid (TCA), taurochenodeoxycholic acid
(TCDCA), taurodeoxycholic acid (TDCA), taurolithocholic acid
(TLCA), tauroursodeoxycholic acid (TUDCA), and ursodeoxycholic
acid (UDCA). The lower limit of quantification (LLOQ) was 0.1 μg/mL
for the 15 BA measured. All samples were analyzed at a single site
(Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA)
according to a standard operating procedure (SOP # PATH.CMS.1065).
The facility is accredited with the College of American Pathologists
(CAP license #1,667,801) and with Clinical Laboratory Improvement
Amendments certification (CLIA 88 license #36D0656333). Duodenal
aspirate samples were extracted using solid phase extraction (SPE)
(21). Serum and plasma bile acid concentrations are expressed as
μmol/L and the total bile acid concentration is represented by the
sum of the individual bile acid species measured. The duodenal bile
acid composition is expressed as percent composition of the individual
bile acid species. The percentage of primary and secondary BA was
calculated as the ratio of the sum of the concentrations of CDCA and
CA to the sum of the concentrations of DCA, LCA, and UDCA in all
their conjugate forms.
Determination of serum 7α-hydroxy-4-cholesten-3-one
by tandem MS
7α-hydroxy-4-cholesten-3-one (sterol-C4) was measured in plasma
using a fully validated stable-isotope dilution LC-ESI-MS assay
according to a proprietary assay developed at Cincinnati Children’s
Hospital Medical Center (CCHMC) (SOP # PATH.CMS.1046).
Hydrophobicity index of bile acid pool
The hydrophobicity index (HI) of the BA pool of plasma and duodenal
aspirate was calculated according to the relative contributions of the
individual BA to the total BA pool and their HIs (22).
Histopathology
Features of EGD biopsy tissue samples were comprehensively assessed
by a team of pathologists at Aga Khan University Hospital (AKUH)
using an EED scoring system developed by the Environmental
Enteric Dysfunction Biopsy Initiative (EEDBI) Consortium. Histological
severity of EED was evaluated using this biopsy scoring system (23) and
score criteria are described in detail in Supplemental Table 1.
Investigated clinical biomarkers of EED
Lactose/rhamnose (L/R) dual sugar permeability testing was conducted
and validated based on EEDBI Consortium protocols. In those children
who underwent endoscopy at AKUH, fecal calorimetry (6200 Isoperibol
Calorimeter; Parr Instrument Company) was used to obtain total
fecal energy content (24). Blood cytokine/chemokine assays used the
MILLIPLEX MAP Human Cytokine/Chemokine panel (EMD Millipore
Corporation). α-1 acid glycoprotein (AGP) or orosomucoid, ferritin,
and C-reactive protein (CRP) were analyzed on an automated biochem-
istry analyzer, Roche/Hitachi 902, and insulin-like growth factor (IGF-I)
was analyzed using a LIAISON Diasorin. All other clinical markers in
urine and fecal EED biomarkers were measured at the age of 3–6 and 9
mo by commercial assay kits as described in detail previously (25).
Statistical analysis
To determine the association of BA with growth, we assessed the
relation between serum BA composition at the age of 9 mo with
WHZ and weight-for-age Z score (WAZ) scores at the age of 24 mo.
Conditional random forests (CRF) analysis was performed to evaluate
the relative importance of initial anthropometry parameters and bile
acids accounting for their correlations with a threshold of ≥0.5. The
top 5 predictors from CRF were further evaluated in a linear regression
model. BA compositions were either log transformed (GUDCA, TCA,
GCA) or dichotomized as 0 compared with >0 (GDCA, TDCA, DCA,
UDCA, LCA) due to their skewed distributions. Statistical tests were
conducted with a 2-sided α level of 0.05. In the case of comparison
of subgroups of Pakistani EED children, slightly less than significant P
was also noted to indicate the trend. For explorative analysis, Pearson’s
correlation was conducted for continuous variables including an
association between BA composition in plasma and duodenal aspirate,
and HAZ. Spearman’s rank correlation was performed to examine the
relation between BA biomarkers and EED histopathological scores.
Due to the explorative nature, no adjustment was performed in these
correlation analyses except for the primary anthropometric response at
24 mo. Dispersion of data was reported as mean ± SEM or 95% CI
unless indicated otherwise. All statistical analysis was conducted in R
Language and Environment for Statistical Computing (www.r-project.
org) or SAS (version 9.4, SAS Institute) statistical software.
Ethics and study approval
Approval for this study was obtained from CCHMC (Study ID 2016–
0387) and AKUH Ethical Review Committee (3836-Ped-ERC-15).




Participants of the study all resided in the rural district of
Matiari, Pakistan, and were enrolled from birth and followed
up to the age of 2 y (2). Among this cohort of 416 infants,
365 children aged between 3–6 mo were assigned to the
undernourished group and 51 children comprised the healthy
nourished control group. Nutrition interventions for children
with wasting at 9 mo (WHZ < -2) consisted of educational
and supplementation programs lasting 2 mo, with monthly
anthropometric measurements collected. In total, 63 children
failed to respond to nutritional intervention by the age of 12–
24 mo and subsequently underwent EGD to diagnose underly-
ing EED. The demographics, growth measurements, and clinical
characteristics of the enrolled children at different time points
are summarized in Tables 1 and 2.
Serum BA profiles at the age of 3–6 and 9 mo in
Pakistani children
Serum BA profiles were quantified for the principal primary and
secondary bile acids at the age of 3–6 and 9 mo and prior to
nutritional intervention in order to study the BA profiles with
EED biomarkers. A total of 730 serum samples were analyzed
from children over these 2 time points. Of these, 680 serum
samples were paired for both age groups and the majority of
the BA detected in serum of both the undernourished and well-
nourished Pakistani children were conjugated with glycine and
taurine (Figure 1, A and B). Seven BA subspecies had serum bile
acid (sBA) concentrations at or above the detection limits of
the assay and these were mainly primary BA. Total serum BA
concentrations in undernourished children were significantly
higher than the healthy controls at the age of 3–6 mo (fold
change = 1.4, P = 0.005) and also at the age of 9 mo (fold
change = 1.3, P = 0.004). Of note, at the age of 3–6 mo,
75% (n = 254) of the undernourished children had a total
sBA concentration well above the 8 μmol/L upper limit of
the normal range for the assay, and higher than the reported
Pakistani normal range (6.52 ± 0.29 μmol/L) (26–28). Aged
9 mo, elevated sBA concentrations persisted, being evident in
64% (n = 190) of these children and consistent with subclinical
chronic liver dysfunction and/or cholestasis.
When individual BA profiles were examined in detail, the
concentration of GCA was significantly elevated in under-
nourished children compared with Pakistani well-nourished
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TABLE 1 Demographics and anthropometrics of Pakistani undernourished and healthy children1
Healthy control (WHZ >0,
HAZ>–1 at enrollment)
Undernourished children
(WHZ < -2 at enrollment)
EGD children (WHZ < -2 after nutritional
intervention and biopsy sample collected)
N 51 365 63
Female, % 24 (47%) 142 (39%) 18 (29%)
Age, m 3–6 9 3–6 9 1.60 (1.52, 1.67)
HAZ − 0.665 (–0.951, –0.379) –0.905 (–1.238, –0.572) –2.361 (–2.515, –2.207) –2.504 (–2.664, –2.344) –3.12 (–3.43, –2.82)
WAZ 0.699 (0.443, 0.955)1 0.638 (0.381, 0.896) –2.63 (–2.70, –2.56) –2.04 (–2.16, –1.91) –3.21 (–3.45, –2.98)
1Data are represented as mean and 95% CI. EGD, esophagogastroduodenoscopy; HAZ, height-for-age Z score; WAZ, weight-for-age Z score; WHZ, weight-for-height Z score.
controls. The concentration of GCA was 2.6- and 2.0-fold
greater at the age of 3–6 and 9 mo, respectively, (both P
<0.001) than the local Pakistani control group, indicating
GCA as a potential biomarker for early growth faltering.
The mean serum concentration of the other major conjugated
primary BA, GCDCA, was also significantly higher at the age
of 3–6 mo (fold change = 1.2, P = 0.04) and 9 mo (fold
change = 1.3, P = 0.003) in undernourished cases compared
with well-nourished controls. We observed a significant negative
correlation between HAZ and the relative proportion of GCA,
expressed as a percentage of the total serum BA in samples at the
age of 3–6 and 9 mo and prior to any nutritional intervention
(Table 3). A correlation network analysis of the serum BA
data revealed a relation among the individual BA species with
2 distinct communities/subgroups of BA evident: one subgroup
consisting of primary BA and another mainly secondary BA
(Figure 2, A and B). This subnetwork structure indicates
the relation and biotransformation of these 2 groups in BA
metabolism. The concentrations of secondary BA in serum
were extremely low for these children, at both time points,
with many samples having concentrations below the LLOQ
of the assay. When expressed as a proportion of the total
serum BA, secondary BA accounted for only 1.13 ± 0.14%
(mean ± SEM) at 3–6 mo but increased as the children became
older, accounting for 1.97 ± 0.15% at the age of 9 mo –
these differences were not clinically significant. Therefore, we
combined all the measured secondary BA concentrations and
investigated these as a single biomarker.
Among blood and fecal EED biomarkers (29) that were
monitored (Table 1 and Supplemental Table 3), AGP, IGF-I,
and urinary claudin-15 showed significant correlations with
linear growth. Analysis of the serum GCA concentrations,
expressed as a percentage of the total sBA (%GCA) showed
a positive association with AGP, a marker for acute and
TABLE 2 Investigated EED biomarkers of Pakistani undernourished and healthy children at 2 study time points1
Healthy control (WHZ >0, HAZ>–1 at enrollment)
n = 51
Undernourished children (WHZ < -2 at enrollment)
n = 365
Age, mo 3–6 9 3–6 9
GLP, pg/mL 1210 (1010, 1420) 2070 (1550, 2550) 1350 (1220, 1480) 1380 (1240, 1520)2
Leptin, pg/mL 408 (363, 454) 305 (259, 350) 173 (158, 187)3 221 (196, 245)2
Ferritin, ng/mL 63.5 (24.9, 102) 22.6 (11.7, 33.5) 136 (122, 150)3 41.0 (30.6, 51.4)4
Prealbumin, mg/dL 15.8 (14.5, 17.0) 15.8 (14.6, 16.9) 14.0 (13.6, 14.4)4 14.5 (14.1, 14.9)4
AGP, mg/dL 104 (92.4, 115) 99.0 (88.5, 109) 103 (96.7, 110) 112 (107, 117)4
CRP, mg/dL 0.360 (0.173, 0.546) 0.219 (0.132, 0.306) 0.481 (0.358, 0.604) 0.633 (0.347, 0.919)2
IGF-I, ng/mL 39.4 (32.0, 46.8) 30.6 (26.0, 35.1) 26.6 (24.6, 28.5)2 23.6 (21.6, 25.7)2
HGB, g/L 10.8 (10.5, 11.2) 10.8 (10.5, 11.2) 10.4 (10.3, 10.6)4 10.4 (10.2, 10.5)4
Rota_IgA, U/mL 186 (10.5, 362) 256 (91.4, 420) 94.2 (29.4, 159) 447 (102, 792)
IP-10, pg/mL 3080 (2340, 3820) 2260 (1730, 2780) 2544 (2330, 2760) 2420 (2150, 2690)
IL-10, pg/mL 73.1 (37.7, 109) 50.4 (20.1, 80.8) 197 (154, 239)3 186 (144, 229)3
INF-γ , pg/mL 17.2 (7.55, 26.9) 19.0 (–0.50, 38.6) 130 (92.0, 167)3 148 (99.3, 196)3
IL-8, pg/mL 34.0 (10.5, 57.5) 36.8 (17.4, 56.2) 130.8 (98.2, 163)3 133 (101, 165)3
IL-1β , pg/mL 5.45 (2.70, 8.20) 3.98 (2.55, 5.42) 38.3 (24.2, 52.4)3 42.4 (21.1, 63.8)3
IL-6, pg/mL 9.47 (4.02, 14.9) 7.26 (4.43, 10.1) 55.1 (34.1, 76.0)3 83.2 (50.8, 115.6)3
IL-12, pg/mL 6.03 (2.61, 9.45) 3.95 (1.94, 5.96) 39.9 (18.3, 61.5)2 60.6 (26.1, 95.0)2
TNF-α, pg/mL 91.1 (47.5, 135) 73.6 (53.9, 93.2) 216 (173, 259)3 207 (163, 250)3
MCP-1, pg/mL 917 (779, 1056) 960 (800, 1120) 1250 (1160, 1330)3 1083 (993, 1170)
Urine claudin-15, ng/mL 0.81 (0.69, 0.93) 0.89 (0.80, 0.97) 1.65 (1.51, 1.78)3 1.93 (1.77, 2.09)3
Urine creatinine, μmol/L 168 (141, 194) 197 (152, 242) 131 (119, 143)4 178 (161, 195)
Fecal myeloperoxidase, ng/mL 19,100 (8270, 30,021) 13,600 (3760, 23,400) 16,400 (12,070, 20,820) 9960 (7770, 12,200)
Fecal neopterin, nmol/L 2260 (1730, 2780) 2530 (1610, 3440) 2220 (2014, 2420) 2270 (2059, 2490)
1Investigated EED biomarkers were measured in blood unless noted otherwise. Data are represented as mean and 95% CI. Difference in each characteristic were evaluated by
student’s t-test. AGP, α-1 acid glycoprotein; CRP, C-reactive protein; EED, environmental enteric dysfunction; HAZ, height-for-age Z score; GLP, glucagon-like peptide 2; HGB,
hemoglobin; IGF-I, insulin-like growth factor I; INF-γ , interferon-γ ; IP-10, interferon-inducible protein 10; MCP-1, monocyte chemoattractant protein 1; WHZ, weight-for-height Z
score.
2P <0.01 compared with the healthy control group at the corresponding time point.
3P <0.001 compared with the healthy control group at the corresponding time point.
4P <0.05 compared with the healthy control group at the corresponding time point.
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FIGURE 1 Serum BA profiles in Pakistani undernourished and healthy children aged between 3 and 6 mo, and 9 mo. (A–B) Serum BA profile in
Pakistani undernourished children and healthy controls aged 3–6 (n = 339 undernourished and 50 healthy controls) and 9 (n = 295 undernourished
and 47 healthy controls) mo. On the left, total BA profiles were plotted (Dashed line indicates 8 μM an upper limit of normal range), and on
the right 7 BA subspecies (out of 15 quantified BA) with >1% of the total BA pool plotted. ∗P <0.05, ∗∗P <0.01, ∗∗∗P <0.001. (C) Scheme
of biosynthesis pathway and metabolic transformations of BA in humans. BA, bile acid; CA, cholic acid; CDCA, chenodeoxycholic acid; DCA,
deoxycholic acid; G, glycine; GCA, glycocholic acid; GCDCA, glycochenodeoxycholic acid; GUDCA, glycoursodeoxycholic acid; LCA, lithocholic
acid; T, taurine; TCA, taurocholic acid; TCDCA, taurochenodeoxycholic acid; UDCA, ursodeoxycholic acid.
chronic inflammation, and claudin-15 at the age of 3–
6 mo (Table 3). Serum GCA also correlated significantly
with proinflammatory cytokines, i.e. cytokine IL-1β at both
assessed time points. IL-1β is a key cytokine involved in both
chronic and acute inflammation in the intestine and is mainly
activated through innate activation of monocytes (30, 31). GCA
concentrations positively correlated with most other measured
proinflammatory cytokines (IFN-γ , IL-10, IL1-β, IL-6, IL-12,
TNF-α) and chemokines (monocyte chemoattractant protein
1 [MCP-1], IL-8, interferon-inducible protein 10 [IP-10])
(Figure 2C). The proportion of secondary BA positively
correlated with prealbumin and IGF-I at the age of 9 mo
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TABLE 3 Correlation between serum BA biomarkers and growth and measured EED biomarkers among Pakistani undernourished
and healthy children aged between 3 and 6 mo and 9 mo1
GCA (%) Secondary BA (%)
Growth and EED








(95% CI) P value
HAZ 3–6 mo 384 –0.252 (–0.343, –0.155) <0.001 –0.054 (–0.154, 0.046) 0.29
9 mo 338 –0.295 (–0.389, –0.194) <0.001 0.089 (–0.018, 0.194) 0.10
WHZ 3–6 mo 384 –0.195 (–0.289, –0.096) <0.001 –0.068 (–0.167, 0.032) 0.18
9 mo 338 –0.167 (–0.268, –0.061) 0.002 0.023 (–0.084, 0.130) 0.67
AGP 3–6 mo 389 0.327 (0.235, 0.414) <0.001 –0.031 (–0.131, 0.069) 0.54
9 mo 340 0.226 (0.122, 0.325) <0.001 –0.074 (–0.180, 0.033) 0.18
IGF–I 3–6 mo 386 –0.152 (–0.248, –0.052) 0.003 –0.107 (–0.205, –0.007) 0.04
9 mo 338 –0.030 (–0.137, 0.078) 0.59 0.120 (0.012, 0.224) 0.03
Prealbumin 3–6 mo 389 0.037 (–0.065, 0.138) 0.47 0.193 (0.093, 0.289) <0.001
9 mo 339 –0.085 (–0.194, 0.027) 0.13 0.163 (0.053, 0.269) 0.004
Urine claudin-15 3–6 mo 384 0.123 (0.022, 0.221) 0.02 0.077 (–0.024, 0.177) 0.14
9 mo 339 0.078 (–0.029, 0.184) 0.15 0.080 (–0.026, 0.186) 0.14
1Dependent on the time of sample collection, monthly anthropometry data that were collected at the closest months of age were used. AGP, α-1 acid glycoprotein; BA, bile
acid; EED, environmental enteric dysfunction; GCA, glycocholic acid; HAZ, height-for-age Z score; IGF-I, insulin-like growth factor I; WHZ, weight-for-height Z score.
(Table 3). To find the potential predictive relation between
BA biomarkers and long-term growth outcome at the age of
24 mo, we also correlated GCA and secondary BA with HAZ
and WHZ. At the age of 9 mo, BA biomarkers significantly
correlated with linear growth (HAZ) of the child at the age
of 24 mo (Supplemental Table 4). Using a conditional random
forest (CRF) model, the top BA biomarkers at the age of 9 mo
that were predictive of linear growth at the age of 24 mo
were UDCA, GCA, TCDCA, GDCA, and DCA (Figure 2D).
The random forests algorithm does not provide directional
relation per se. However, we obtained the directionality from
a multiple linear model with adjustment for initial HAZ, WHZ,
and WAZ (Supplemental Table 5). Among these BA subspecies,
directionality of UDCA, DCA, and GUDCA were positive to
HAZ at 24 mo, whereas GCA was negatively correlated. Results
of the corresponding top BA biomarkers for predicting WHZ
and WAZ outcomes are summarized in Supplemental Figure 2.
BA dysregulation associates with histopathological
severity in EED children
Duodenal biopsy samples from Pakistani EED children
were scored based on acute and chronic inflammation,
villus architecture, secretory cells, enterocyte injury, epithe-
lial detachment, and others (2). Representative hematoxylin
and eosin staining (H&E) duodenal histology from un-
dernourished EED children are shown in Figure 3A. The
EED cases demonstrated intramucosal Brunner gland hyper-
plasia and villous blunting, and more pronounced Paneth
cell depletion (Supplemental Figure 3). Correlations between
potential BA biomarkers including GCA and secondary BA
and the total EED histological scores are summarized in
Table 4 and Figure 3B.
BA profiles of plasma and duodenal aspirate samples
of Pakistani EED children
The clinical features of Pakistani EED children are summarized
in Supplemental Tables 6 and 7. To overcome the limitation of
lacking EGD samples from local healthy Matiari controls (as
it was deemed not ethically possible to perform endoscopy on
well-nourished infants), we evaluated the histological composite
score by dividing the EED children into 2 subgroups according
to histological severity, those below the 50th percentile (whose
histological score ≤median score, n = 33) and those above
the 50th percentile (whose histological score >median score,
n = 30).
A total of 41 duodenal aspirates were successfully col-
lected (2 samples had undetectable concentrations of total
bile acids and were therefore excluded from data analysis)
and 55 plasma samples were analyzed. It was notable that
dysregulated BA metabolism was more pronounced in the
cases of EED children with a histological score above the
50th percentile compared with those below the 50th percentile
(Supplemental Figure 4A and B). Notably, in the aspirates,
GCA was present in marginally significant greater proportions
(P = 0.051), and conjugated secondary BA, i.e., GDCA, and
GUDCA, were found in lower proportions in the severe EED
cases. It was observed that HAZ and WAZ were worse in
children with severe EED scores but not statistically significant
(Supplemental Table 2). Importantly, a marginally significant
decrease in secondary BA (P = 0.088) was observed in
the duodenum of more severe EED children (Supplemental
Figure 5A) and delineated a potentially inactive BA transfor-
mation in the gut of EED patients. The mean plasma sterol-
C4 concentration, a surrogate marker for bile acid synthesis
rate, in the Pakistani EED cohort was not statistically significant
between mild and severe groups (P = 0.75) (Supplemental
Figure 5B).
Although unconjugated BA in duodenal aspirates in EED
children were negligible (<1%), by contrast, plasma con-
centrations of unconjugated BAs were significantly higher.
However, there was no significant difference in the proportions
of conjugated BA in Pakistani EED children (P = 0.37
and 0.44, respectively) between the 2 subsets (Supplemental
Figure 6A).
The calculated HIBA of duodenal aspirates increased in
severe EED children compared to children with less severe
disease. We also observed a similar increase of HIBA in plasma
but differences were not statistically significant (Supplemental
Figure 6A). As cholestasis is associated with fat malabsorption,
bomb calorimetry was performed on a single stool specimen
from EED children to provide a readout of the intestinal
absorption and fecal energy (32) (Supplemental Figure 6B). It
showed that GCA (%) positively correlated, whereas secondary
BA (%) and HIBA in plasma and duodenal aspirates negatively
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FIGURE 2 Association of BA subspecies and correlation to cytokines of Pakistani undernourished and healthy children aged between 3 and 6
mo, and 9 mo. (A–B) Correlation network analysis of serum BA subspecies concentration at the age of 3–6 mo (n = 389), and 9 mo (n = 342).
GLCA and TLCA were not included in the 3–6 mo plot due to their extremely low concentration in the sample. (C) Correlation of GCA (%) in serum
and proinflammatory cytokines (n = 384 and 339 aged 3–6 mo and 9 mo, respectively). (D) Conditional random forest (CRF) model identified
the top 5 important BA in predicting height-for-age Z score at 24 mo (linear growth) using the 9 mo data set consisted of 277 Pakistani children.
BA, bile acid; CA, cholic acid; CDCA, chenodeoxycholic acid; DCA, deoxycholic acid; GCA, glycocholic acid; GCDCA, glycochenodeoxycholic
acid; GDCA, glycodeoxycholic acid; GLCA, glycolithocholic acid; GUDCA, glycoursodeoxycholic acid; LCA, lithocholic acid; TCA, taurocholic
acid; TCDCA, taurochenodeoxycholic acid; TDCA, taurodeoxycholic acid; TLCA, taurolithocholic acid; TUDCA, tauroursodeoxycholic acid; UDCA,
ursodeoxycholic acid.
correlated, with fecal energy wasting; however, this was not
statistically significant.
The correlations between BA biomarkers and investigated
clinical blood results are summarized in Figure 3C. Of note,
plasma BA composition at the time of EGD (Figure 4A) showed
a similar qualitative pattern to that of duodenal aspirates.
There was a high correlation between the duodenal aspirate
and plasma BA composition when bile acids were expressed
as (%) total secondary BA (Pearson’s r = 0.796) and GCA
(Pearson’s r = 0.564), indicating plasma BA composition reflects
duodenal BA composition. We observed a significant correlation
between plasma GCA (%) and the total EED histopathological
score, and a negative correlation in secondary BA (%) in
both plasma and duodenal aspirates. In particular, plasma
GCA significantly correlated with Paneth cell depletion and
the proportion of secondary BAs significantly correlated with
intramucosal Brunner gland scores. The proportion of GCA
in plasma and duodenal aspirates positively correlated with
platelet and white blood cell counts, and with markers of
systemic inflammation, whereas the proportion of plasma sec-
ondary BA negatively and significantly correlated with platelet
count.
Discussion
The goals of this study, which comprised 416 Pakistani children
(365 undernourished and 51 age-matched well-nourished
controls) prospectively followed over 2 y were to determine
the extent to which: 1) bile acid metabolism is altered in
undernourished children and 2) if measures of the serum and
duodenal BA metabolome could reveal specific biomarkers of
EED pathology to predict later growth outcome. A targeted
metabolomics approach used tandem MS to profile the major
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FIGURE 3 Histopathological analysis of EED children and association to plasma and duodenal aspirate BA composition. (A) Representative
hematoxylin and eosin staining (H&E) duodenal histology from an undernourished EED child. Arrowhead indicates villous blunting, short arrow
indicates Paneth cell, and long arrow indicates intramucosal Brunner gland hyperplasia. (B) Correlation of percent secondary BA and GCA in
plasma and duodenal aspirates (n = 63 EED children) with histopathological EED scores. (C) BA profile associates with clinical investigation
blood test results in Pakistani EED children. Pearson correlation of GCA and secondary BA (%) in duodenal aspirate (n = 39) and plasma (n = 55)
to clinical investigation lab results of Pakistani EED children. ∗P <0.05. BA, bile acid; EED, environmental enteric dysfunction; GCA, glycocholic
acid; MCH, mean corpuscular hemoglobin concentration; RBC, red blood cell count; WBC, white blood cell count.
conjugated and unconjugated sBA. Sulfated BA, which are
mainly excreted in urine, were not measured due to their
relatively low concentrations in the serum (33). Our serial
BA measurements in these infants suggest undernutrition and
EED-associated bile acid dysregulation: 1) occurs earlier in
childhood than previously appreciated, 2) precedes moderate
acute malnutrition, and 3) is not geographically restricted
to sub-Saharan Africa. Furthermore, a remarkable finding
was the high proportion of undernourished children with
persistently elevated total sBA concentrations consistent with
liver dysfunction.
SBA reflect the balance between intestinal input and
hepatic extraction and are influenced by changes in hepatic
synthesis and secretion as well as intestinal metabolism by
the microbiome (34). The concentration and composition of
BA in serum provides a sensitive indicator of the extent of
hepatic dysfunction, of cholestasis, and of small bowel bacterial
overgrowth (35–37). Therefore, disturbances in BA synthesis,
secretion, or intraluminal bacterial metabolism can have a
profound effect on lipid absorption and growth, as is evident
in patients that have neonatal and infantile cholestasis, in
genetic disorders of bile acid synthesis (38), and in cases of
increased fecal bile acid loss (39). Our findings of disrupted BA
homeostasis in undernourished children as young as 3–6 mo
has implications for the absorption of preventive lipid-based
nutrient supplements beyond the age of 6 mo in this and other
settings. Further, the persistence of this disrupted homeostasis
in children with refractory wasting provides insights into the
judicious use of high lipid-based nutrient supplements to reverse
moderate- and severe-acute malnutrition (40).
The primary bile acids CA and CDCA are secreted in
bile almost exclusively (>99%) in a conjugated form, mainly
as glycine and taurine conjugates. These primary bile acids
undergo an initial intestinal hydrolysis by bacterial bile salt
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TABLE 4 Correlation between BA composition and total histopathological EED score among







(95% CI) P value
Correlation total histopathological EED score and GCA (%)
Plasma 55 0.324 (0.064, 0.543) 0.02
Duodenal aspirate 39 0.307 (–0.009, 0.568) 0.06
Correlation total histopathological EED score and secondary BA (%)
Plasma 55 –0.121 (–0.374, 0.149) 0.38
Duodenal aspirate 39 –0.237 (–0.514, 0.085) 0.15
1Spearman rank correlation performed for correlation of histopathological EED score of Pakistani EGD children, secondary BA (%)
and GCA (%). BA, bile acid; EED, environmental enteric dysfunction; EGD, esophagogastroduodenoscopy; GCA, glycocholic acid.
hydrolases and are then dehydroxylated by bacterial 7α-
dehydroxylase to form the secondary bile acids, DCA and LCA
(41), or further metabolized by epimerases (42) (Figure 1C). A
remarkable finding from this study was the high proportion
(>70%) of the undernourished children with total sBA
concentrations, predominately conjugated, well above the upper
limit of the normal range and consistent with mild cholestasis.
When individual BA species were compared, serum GCA was
found to be consistently elevated in undernourished children
when compared with the cohort of Pakistani well-nourished,
age-matched controls, and seemingly a useful biomarker for
growth faltering. Although BA metabolism has been studied in
the context of EED and in undernourished children in Malawi
(11, 12), the findings are inconsistent, perhaps due to differences
in the severity of undernutrition between the 2 Malawian
cohorts. Total sBA, GCA, and GCDCA were reported to be
increased in older Malawian children (age range 6–60 mo) with
SAM (12), however, total sBA were ∼12% lower in a separate
cohort of children with EED versus children without EED
(11). Thus, our findings in undernourished Pakistani infants
are more concordant with those from Malawian children with
SAM, whose mean age was greater (24.8 ± 11.7 mo) and
whose severity of undernutrition required hospitalization. In
our study, elevated total BA concentrations were sustained
from up to the age of 9 mo, suggesting disrupted bile acid
homeostasis occurs prior to the onset of clinically significant
ponderal and linear growth faltering. Indeed, such high total
sBA concentrations, with low concentrations of the secondary
bile acid, DCA, is indicative of significant cholestasis (35–
37), as defined by impaired organic anion transport and liver
dysfunction, and not because of any global differences in
normal ranges (27, 28). This was an unexpected finding, and
as liver function tests were never performed at the time of
blood collection, it is not possible to know whether serum
transaminases were also elevated. These findings, which point
to subclinical cholestasis, now make a strong case for routinely
performing serum liver function tests (LFTs) on undernourished
children with suspected EED. Although these children did
not have obvious jaundice we speculate that: 1) elevations
in sBA indicate canalicular secretion of BA into bile may be
compromised and 2) intraluminal bile acid concentrations may
be below the critical micellar concentration (CMC) required for
efficient lipid absorption, with consequent adverse effects on
growth.
Uniquely in our study, the collection of duodenal aspirates
and biopsies in those children unresponsive to nutritional
intervention allowed for direct comparisons of plasma and
duodenal bile acid profiles and correlations of bile acid
composition with EED histopathology. It is not possible to
accurately determine biliary bile acid concentrations because
samples were not from the common bile duct and were not
‘pure bile,’ but rather bile diluted by gastric, pancreatic, and
duodenal secretions. This makes concentrations difficult to
interpret and typically leads to large interindividual variations
in concentrations, as was evident from our data. For this reason,
BA composition in such samples is typically expressed as percent
composition for the individual species. Nevertheless, it was
observed that the correlation trends were similar when absolute
concentrations of BA were used (data not shown) and this
information defines the composition of the BA pool.
Due to ethical constraints and the rarity of upper endoscopy
performed in healthy young children living in Pakistan,
comparison of duodenal aspirate data for the EED cases and a
healthy Pakistani control group was not possible. To circumvent
this problem, we retrospectively compared the bile acid profiles
in those EED patients ranked above the 50th percentile to those
below the 50th percentile based on the composite histological
EED score even allowing for the limitation that the median
EED composite score may not be perfect for the stratification
of subgroups. Nevertheless, it provided a practical metric to
evaluate the relevance of biomarkers in the absence of a healthy
control group of locally age-matched children.
The finding of an association between secondary BA
deficiency and EED is consistent with the hypothesis that the
gut microbiome of EED children may also be compromised.
Nutritional deficiency and enteropathogen exposure in EED
lead to a suboptimal microbial community and injured small
intestine (3, 4). In the gut-liver axis, host metabolism and
gut microbiome crosstalk, partly through signaling molecules
such as BA, modulate and influence each other (Figure 4B).
In children with EED, primary BA were elevated in blood and
secondary BA decreased in duodenal aspirates. Secondary BA
depletion in the gut can result in gut microbiome changes and
vice versa.
There are many reports on the role of BA in the
maintenance of microbiota homeostasis and on the mucosal
immune system in the intestine (14, 43). Duodenal dysbiosis
in stunted Bangladeshi children with EED has been reported
(19). Secondary BA deficiency in the duodenum of EED
children could correlate with imbalance of the duodenal
microbiome. Interestingly, the proportions of GCA positively,
and secondary BA negatively, correlated with Paneth cell
depletion in EED children (Figure 3B) suggesting possible
pathogenic mechanisms involving altered gut microbiota. In
a separate publication of this SEEM it was reported that
EED cases had more pronounced Paneth cell depletion when
compared with a cohort of celiac patients (20). Our results show
that the proportions of serum GCA positively correlated with
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FIGURE 4 Correlation of plasma and duodenal aspirate GCA and secondary BA and their potential role as a disease-relevant signature in EED.
(A) Correlation of percent GCA and secondary BAs in plasma and duodenal aspirates of EED children (n = 35). (B) Schematic illustration of BA
signatures in undernourished EED children. BA, bile acid; EED, environmental enteric dysfunction; GCA, glycocholic acid.
most measured proinflammatory cytokines and chemokines
in early infancy. This raises the possibility of treating EED
patients by targeting and manipulating BA composition through
probiotics, prebiotics, synbiotics, or microbiome-directed diets
(44). Animal studies have shown oral BA administration
markedly alters the microbiome (45). Fecal bile acid analysis
may reveal differences in the microbiome of undernourished
children and those with EED (46) but feces (and urine) from
undernourished children were not analyzed in our study. The
development of a more simplistic assay for measuring GCA for
use as a potential biomarker for growth outcomes in resource-
restricted labs may be possible in the future.
The main limitations of such a complex and challenging
study include the focus on only Pakistani children, so it is
unclear if our findings generalize to other undernourished
populations with EED, and the lack of a control group
because performing upper endoscopy in healthy local Pakistani
controls was not ethically justified. Despite these limitations,
our findings reveal distinct BA biomarkers relevant to EED
pathology. Previous studies have shown some heterogeneity
in EED biomarkers. In a recent report, Mutasa et al. found
none of the 11 putative biomarkers of EED investigated were
associated with linear growth among Zimbabwean children
during the first 18 mo of life (10); however, bile acids were not
included. Reliable biomarkers that correlate with EED severity
and growth trajectories remain an urgent need.
The strengths and unique aspects of our study include: 1)
a sizable cohort of undernourished children studied longitu-
dinally for their bile acid metabolome, 2) the identification
of an early life specific biomarker predicting growth outcome
at the age of 2 y, 3) the findings of significant cholestasis in
undernourished children, 4) the detailed study of a subgroup of
children who underwent mucosal biopsy histologic evaluation
for refractory wasting to gain a mechanistic insight in EED,






/jn/advance-article/doi/10.1093/jn/nxab321/6412922 by Aga Khan U
niversity, H
ealth Sciences Library user on 10 N
ovem
ber 2021
and 5) establishment of a relationship between blood and
duodenal BA composition to other clinical and exploratory
markers of EED.
In summary, our findings reveal a potential biochemical
signature for EED pathogenesis and identification of GCA
as a specific biomarker for predicting growth outcome in
undernourished infants, opening the possibility to explore
future therapeutics that may alter the bile acid metabolome.
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